CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale EXECUTIVE CHAIRMAN sold 1,000 shares at $280.00 ($280,000)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 16,800 shares at an average $272.29 ($4,574,431)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $272.90 ($818,711)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 75 shares (grant or award)
- 4 Grant or award Director acquired 1,677 shares (grant or award)
- 4 Grant or award Director acquired 1,669 shares (grant or award)
- 4 Grant or award Director acquired 1,905 shares (grant or award)
- 4 Grant or award Director acquired 1,674 shares (grant or award)
- 4 Grant or award Director acquired 1,691 shares (grant or award)
- 4 Grant or award Director acquired 1,646 shares (grant or award)
- 4 Grant or award Director acquired 1,646 shares (grant or award)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 33,600 shares at an average $251.65 ($8,455,355)
- 4 Planned sale Director sold 16,530 shares at $250.00 ($4,132,500)
Page 7 of 94 · 1,862 filings